BFONX
Price
$22.73
Change
-$0.26 (-1.13%)
Updated
Nov 18 closing price
Net Assets
51.08M
GFACX
Price
$72.97
Change
-$0.51 (-0.69%)
Updated
Nov 18 closing price
Net Assets
329.73B
Interact to see
Advertisement

BFONX vs GFACX

Header iconBFONX vs GFACX Comparison
Open Charts BFONX vs GFACXBanner chart's image
Biondo Focus Investor
Price$22.73
Change-$0.26 (-1.13%)
VolumeN/A
Net Assets51.08M
American Funds Growth Fund of Amer C
Price$72.97
Change-$0.51 (-0.69%)
VolumeN/A
Net Assets329.73B
BFONX vs GFACX Comparison Chart in %
View a ticker or compare two or three
VS
BFONX vs. GFACX commentary
Nov 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BFONX is a Hold and GFACX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 330B vs. BFONX (51.1M). BFONX pays higher dividends than GFACX: BFONX (0.20) vs GFACX (0.00). BFONX was incepted earlier than GFACX: BFONX (16 years) vs GFACX (25 years). BFONX (1.80) is less costly to investors than GFACX (1.36). GFACX is a more actively managed with annual turnover of: 25.00 vs. BFONX (14.00). GFACX has a lower initial minimum investment than BFONX: GFACX (250) vs BFONX (1000). GFACX annual gain was more profitable for investors over the last year : 5.07 vs. BFONX (-9.66). GFACX return over 5 years is better than : 24.08 vs. BFONX (-0.53).
BFONXGFACXBFONX / GFACX
Total Expense Ratio1.501.36110%
Annual Report Gross Expense Ratio1.801.36132%
Fund Existence16 years25 years-
Gain YTD6.88114.44548%
Front LoadN/AN/A-
Min. Initial Investment1000250400%
Min. Initial Investment IRAN/AN/A-
Net Assets51.1M330B0%
Annual Yield % from dividends0.200.00-
Returns for 1 year-9.665.07-191%
Returns for 3 years49.5054.8690%
Returns for 5 years-0.5324.08-2%
Returns for 10 years49.6969.6671%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
NRXBF0.50N/A
+0.90%
NUREXONE BIOLOGIC INC
NDEKF23.90N/A
N/A
Nitto Denko Corp.
NEVIF0.04N/A
-0.23%
Nevis Brands Inc.
NLLSF0.23-0.01
-4.15%
Nel ASA
SNPHY10.18-0.50
-4.68%
Santen Pharmaceutical Co., Ltd.